Armata Pharmaceuticals, Inc. (ARMP)
5.83
+0.31
(+5.62%)
USD |
NYAM |
Sep 04, 16:00
5.83
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Debt to Equity Ratio : -1.358 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.358 |
| March 31, 2026 | -1.199 |
| December 31, 2025 | -1.318 |
| September 30, 2025 | -1.859 |
| June 30, 2025 | -2.071 |
| March 31, 2025 | -2.504 |
| December 31, 2024 | -2.635 |
| September 30, 2024 | -2.753 |
| June 30, 2024 | -3.17 |
| March 31, 2024 | -2.971 |
| December 31, 2023 | -3.754 |
| September 30, 2023 | -9.174 |
| June 30, 2023 | 3.568 |
| March 31, 2023 | 3.445 |
| December 31, 2022 | 1.353 |
| September 30, 2022 | 0.8655 |
| June 30, 2022 | 0.7307 |
| March 31, 2022 | 0.6247 |
| December 31, 2021 | 1.496 |
| September 30, 2021 | 0.5184 |
| June 30, 2021 | 0.4568 |
| March 31, 2021 | 0.3854 |
| December 31, 2020 | 0.6974 |
| September 30, 2020 | 0.5295 |
| June 30, 2020 | 0.4272 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0762 |
| December 31, 2019 | 0.1962 |
| September 30, 2019 | 0.1738 |
| June 30, 2019 | 0.1625 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0313 |
| June 30, 2017 | 0.0615 |
| March 31, 2017 | 0.09 |
| December 31, 2016 | 0.0826 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -45.66 |
| December 31, 2014 | 2.270 |
| September 30, 2014 | 2.330 |
| June 30, 2014 | -2.014 |
| March 31, 2014 | -1.522 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 89.95M |
| Total Liabilities (Quarterly) | 321.12M |
| Shareholders Equity (Quarterly) | -231.17M |
| Current Ratio | 0.1085 |
| Net Debt Paydown Yield | -14.90% |